Home
Market Capitalization of Onesource Specialty Pharma Ltd

OneSource Specialty Pharma Ltd
NSE: ONESOURCE
Market Cap
Key Highlights
- The Market Cap of OneSource Specialty Pharma Ltd is ₹ 14154 crore as of 28 Feb 25 .
- The Latest Trading Price of OneSource Specialty Pharma Ltd is ₹ 1305 as of 03 Mar 15:31 .

OneSource Specialty Pharma Ltd
NSE: ONESOURCE
Share Price
Market Price of OneSource Specialty Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
28 Feb 2025 | 1236.85 |
27 Feb 2025 | 1291.25 |
25 Feb 2025 | 1349.4 |
24 Feb 2025 | 1327 |
21 Feb 2025 | 1277.45 |
20 Feb 2025 | 1328.9 |
19 Feb 2025 | 1331.95 |
18 Feb 2025 | 1359.7 |
17 Feb 2025 | 1333.2 |
14 Feb 2025 | 1444.9 |
SWOT Analysis Of OneSource Specialty Pharma Ltd
BlinkX Score for OneSource Specialty Pharma Ltd
Asset Value vs Market Value of OneSource Specialty Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of OneSource Specialty Pharma Ltd
Historical P/E Ratio of OneSource Specialty Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of OneSource Specialty Pharma Ltd
Historical Revenue of OneSource Specialty Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of OneSource Specialty Pharma Ltd
Historical EBITDA of OneSource Specialty Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of OneSource Specialty Pharma Ltd
Historical Net Profit of OneSource Specialty Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of OneSource Specialty Pharma Ltd
Dividend Payout Over Time
About OneSource Specialty Pharma Ltd
- Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
- The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
- The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
- Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.
OneSource Specialty Pharma Ltd News Hub
OneSource Specialty Pharma to convene board meeting
OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on 29 Januar
Read more
25 Jan 25
Shares of Onesource Specialty Pharma list in T Group
The equity shares of Onesource Specialty Pharma (Scrip Code: 544292) are listed effective 24 January
Read more
24 Jan 25
OneSource Specialty Pharma reports consolidated net loss of Rs 68.85 crore in the December 2024 quarter
Net Loss of OneSource Specialty Pharma reported to Rs 68.85 crore in the quarter ended December 2024
Read more
29 Jan 25